Roger Adsett
Chief Operating Officer chez INSMED INCORPORATED
Fortune : 4 M $ au 31/03/2024
Profil
Roger Adsett is currently an Independent Director at Landos Biopharma, Inc. since 2022.
He is also currently serving as the Chief Operating Officer at Insmed, Inc. since 2016.
Previously, he worked at AstraZeneca PLC as the Director of Marketing & Brand from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. From 2005 to 2016, he worked at Shire Plc as the SVP and Head of Gastrointestinal & Internal Medicine.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED
0,10% | 12/01/2024 | 148 559 ( 0,10% ) | 4 M $ | 31/03/2024 |
LANDOS BIOPHARMA, INC.
-.--% | 23/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Roger Adsett
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 14/11/2019 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 08/03/2022 |
Anciens postes connus de Roger Adsett
| Sociétés | Poste | Fin |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 01/09/2016 |
| ASTRAZENECA PLC | Sales & Marketing | 01/10/2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Formation de Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
